Literature DB >> 25143292

FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution.

Aaron M Newman1, Scott V Bratman1, Henning Stehr2, Luke J Lee1, Chih Long Liu1, Maximilian Diehn3, Ash A Alizadeh3.   

Abstract

UNLABELLED: For practical and robust de novo identification of genomic fusions and breakpoints from targeted paired-end DNA sequencing data, we developed Fusion And Chromosomal Translocation Enumeration and Recovery Algorithm (FACTERA). Our method has minimal external dependencies, works directly on a preexisting Binary Alignment/Map file and produces easily interpretable output. We demonstrate FACTERA's ability to rapidly identify breakpoint-resolution fusion events with high sensitivity and specificity in patients with non-small cell lung cancer, including novel rearrangements. We anticipate that FACTERA will be broadly applicable to the discovery and analysis of clinically relevant fusions from both targeted and genome-wide sequencing datasets.
AVAILABILITY AND IMPLEMENTATION: http://factera.stanford.edu.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2014        PMID: 25143292      PMCID: PMC4296148          DOI: 10.1093/bioinformatics/btu549

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  18 in total

1.  Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors.

Authors:  David J McBride; Arto K Orpana; Christos Sotiriou; Heikki Joensuu; Philip J Stephens; Laura J Mudie; Eija Hämäläinen; Lucy A Stebbings; Leif C Andersson; Adrienne M Flanagan; Virginie Durbecq; Michail Ignatiadis; Olli Kallioniemi; Caroline A Heckman; Kari Alitalo; Henrik Edgren; P Andrew Futreal; Michael R Stratton; Peter J Campbell
Journal:  Genes Chromosomes Cancer       Date:  2010-11       Impact factor: 5.006

2.  Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Authors:  Eunice L Kwak; Yung-Jue Bang; D Ross Camidge; Alice T Shaw; Benjamin Solomon; Robert G Maki; Sai-Hong I Ou; Bruce J Dezube; Pasi A Jänne; Daniel B Costa; Marileila Varella-Garcia; Woo-Ho Kim; Thomas J Lynch; Panos Fidias; Hannah Stubbs; Jeffrey A Engelman; Lecia V Sequist; WeiWei Tan; Leena Gandhi; Mari Mino-Kenudson; Greg C Wei; S Martin Shreeve; Mark J Ratain; Jeffrey Settleman; James G Christensen; Daniel A Haber; Keith Wilner; Ravi Salgia; Geoffrey I Shapiro; Jeffrey W Clark; A John Iafrate
Journal:  N Engl J Med       Date:  2010-10-28       Impact factor: 91.245

3.  ROS1 rearrangements define a unique molecular class of lung cancers.

Authors:  Kristin Bergethon; Alice T Shaw; Sai-Hong Ignatius Ou; Ryohei Katayama; Christine M Lovly; Nerina T McDonald; Pierre P Massion; Christina Siwak-Tapp; Adriana Gonzalez; Rong Fang; Eugene J Mark; Julie M Batten; Haiquan Chen; Keith D Wilner; Eunice L Kwak; Jeffrey W Clark; David P Carbone; Hongbin Ji; Jeffrey A Engelman; Mari Mino-Kenudson; William Pao; A John Iafrate
Journal:  J Clin Oncol       Date:  2012-01-03       Impact factor: 44.544

4.  CREST maps somatic structural variation in cancer genomes with base-pair resolution.

Authors:  Jianmin Wang; Charles G Mullighan; John Easton; Stefan Roberts; Sue L Heatley; Jing Ma; Michael C Rusch; Ken Chen; Christopher C Harris; Li Ding; Linda Holmfeldt; Debbie Payne-Turner; Xian Fan; Lei Wei; David Zhao; John C Obenauer; Clayton Naeve; Elaine R Mardis; Richard K Wilson; James R Downing; Jinghui Zhang
Journal:  Nat Methods       Date:  2011-06-12       Impact factor: 28.547

5.  Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.

Authors:  Y Tsujimoto; L R Finger; J Yunis; P C Nowell; C M Croce
Journal:  Science       Date:  1984-11-30       Impact factor: 47.728

6.  Development of personalized tumor biomarkers using massively parallel sequencing.

Authors:  Rebecca J Leary; Isaac Kinde; Frank Diehl; Kerstin Schmidt; Chris Clouser; Cisilya Duncan; Alena Antipova; Clarence Lee; Kevin McKernan; Francisco M De La Vega; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz; Victor E Velculescu
Journal:  Sci Transl Med       Date:  2010-02-24       Impact factor: 17.956

7.  Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors.

Authors:  Ultan McDermott; A John Iafrate; Nathanael S Gray; Toshi Shioda; Marie Classon; Shyamala Maheswaran; Wenjun Zhou; Hwan Geun Choi; Shannon L Smith; Lori Dowell; Lindsey E Ulkus; Georgiana Kuhlmann; Patricia Greninger; James G Christensen; Daniel A Haber; Jeffrey Settleman
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

8.  Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

Authors:  Marcin Imielinski; Alice H Berger; Peter S Hammerman; Bryan Hernandez; Trevor J Pugh; Eran Hodis; Jeonghee Cho; James Suh; Marzia Capelletti; Andrey Sivachenko; Carrie Sougnez; Daniel Auclair; Michael S Lawrence; Petar Stojanov; Kristian Cibulskis; Kyusam Choi; Luc de Waal; Tanaz Sharifnia; Angela Brooks; Heidi Greulich; Shantanu Banerji; Thomas Zander; Danila Seidel; Frauke Leenders; Sascha Ansén; Corinna Ludwig; Walburga Engel-Riedel; Erich Stoelben; Jürgen Wolf; Chandra Goparju; Kristin Thompson; Wendy Winckler; David Kwiatkowski; Bruce E Johnson; Pasi A Jänne; Vincent A Miller; William Pao; William D Travis; Harvey I Pass; Stacey B Gabriel; Eric S Lander; Roman K Thomas; Levi A Garraway; Gad Getz; Matthew Meyerson
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

9.  DELLY: structural variant discovery by integrated paired-end and split-read analysis.

Authors:  Tobias Rausch; Thomas Zichner; Andreas Schlattl; Adrian M Stütz; Vladimir Benes; Jan O Korbel
Journal:  Bioinformatics       Date:  2012-09-15       Impact factor: 6.937

10.  Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.

Authors:  A Vaishnavi; M Capelletti; P A Jänne; R C Doebele; A T Le; S Kako; M Butaney; D Ercan; S Mahale; K D Davies; D L Aisner; A B Pilling; E M Berge; J Kim; H Sasaki; S Park; G Kryukov; L A Garraway; Peter S Hammerman; J Haas; S W Andrews; D Lipson; P J Stephens; V A Miller; M Varella-Garcia
Journal:  Nat Med       Date:  2013-10-27       Impact factor: 53.440

View more
  92 in total

1.  Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.

Authors:  Fangjun Chen; Zhengyun Zou; Juan Du; Shu Su; Jie Shao; Fanyan Meng; Ju Yang; Qiuping Xu; Naiqing Ding; Yang Yang; Qin Liu; Qin Wang; Zhichen Sun; Shujuan Zhou; Shiyao Du; Jia Wei; Baorui Liu
Journal:  J Clin Invest       Date:  2019-03-05       Impact factor: 14.808

Review 2.  Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA).

Authors:  Re-I Chin; Kevin Chen; Abul Usmani; Chanelle Chua; Peter K Harris; Michael S Binkley; Tej D Azad; Jonathan C Dudley; Aadel A Chaudhuri
Journal:  Mol Diagn Ther       Date:  2019-06       Impact factor: 4.074

3.  Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib.

Authors:  Yudong Su; Xiang Long; Yang Song; Peng Chen; Shanqing Li; Huaxia Yang; Pancheng Wu; Yanyu Wang; Zhongxing Bing; Zhili Cao; Lei Cao; Yijun Wu; Zhe Zhang; Jing Liu; Bing Li; Jianxing Xiang; Ke Ma; Tengfei Zhang; Lu Zhang; Xinru Mao; Hao Liu; Puyuan Xing; Naixin Liang
Journal:  Target Oncol       Date:  2019-04       Impact factor: 4.493

4.  A novel mechanism of NPM1 cytoplasmic localization in acute myeloid leukemia: the recurrent gene fusion NPM1-HAUS1.

Authors:  Paulo Vidal Campregher; Welbert de Oliveira Pereira; Bianca Lisboa; Renato Puga; Elvira Rodrigues Pereira Velloso Deolinda; Ricardo Helman; Luciana Cavalheiro Marti; João Carlos Campos Guerra; Kalliopi N Manola; Roberta Cardoso Petroni; Alanna Mara Pinheiro Sobreira Bezerra; Fernando Ferreira Costa; Nelson Hamerschlak; Fábio Pires de Souza Santos
Journal:  Haematologica       Date:  2016-04-01       Impact factor: 9.941

5.  Mutation Profile of Resected EGFR-Mutated Lung Adenocarcinoma by Next-Generation Sequencing.

Authors:  Ze-Rui Zhao; Yao-Bin Lin; Calvin S H Ng; Rong Zhang; Xue Wu; Qiuxiang Ou; Wendan Chen; Wen-Jie Zhou; Yong-Bin Lin; Xiao-Dong Su; Yang W Shao; Hao Long
Journal:  Oncologist       Date:  2019-03-14

Review 6.  Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.

Authors:  Aadel A Chaudhuri; Michael S Binkley; Evan C Osmundson; Ash A Alizadeh; Maximilian Diehn
Journal:  Semin Radiat Oncol       Date:  2015-05-15       Impact factor: 5.934

7.  Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.

Authors:  Alexander Ungewickell; Aparna Bhaduri; Eon Rios; Jason Reuter; Carolyn S Lee; Angela Mah; Ashley Zehnder; Robert Ohgami; Shashikant Kulkarni; Randall Armstrong; Wen-Kai Weng; Dita Gratzinger; Mahkam Tavallaee; Alain Rook; Michael Snyder; Youn Kim; Paul A Khavari
Journal:  Nat Genet       Date:  2015-08-10       Impact factor: 38.330

8.  Liquid biopsies using pleural effusion-derived exosomal DNA in advanced lung adenocarcinoma.

Authors:  Zhengbo Song; Zhijian Cai; Junrong Yan; Yang W Shao; Yiping Zhang
Journal:  Transl Lung Cancer Res       Date:  2019-08

9.  Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.

Authors:  Florian Scherer; David M Kurtz; Aaron M Newman; Henning Stehr; Alexander F M Craig; Mohammad Shahrokh Esfahani; Alexander F Lovejoy; Jacob J Chabon; Daniel M Klass; Chih Long Liu; Li Zhou; Cynthia Glover; Brendan C Visser; George A Poultsides; Ranjana H Advani; Lauren S Maeda; Neel K Gupta; Ronald Levy; Robert S Ohgami; Christian A Kunder; Maximilian Diehn; Ash A Alizadeh
Journal:  Sci Transl Med       Date:  2016-11-09       Impact factor: 17.956

10.  Exploratory analysis of introducing next-generation sequencing-based method to treatment-naive lung cancer patients.

Authors:  Yufang Feng; Gaohua Feng; Xiaoling Lu; Wenxia Qian; Junyi Ye; Carmen Areses Manrique; Chunping Ma; Yadong Lu
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.